Business Wire

ISACA Research: Only 4 in 10 Tech Professionals Confident in Security of Their Organizations’ AI Deployments

Del

Despite heightened interest in enterprise deployment of artificial intelligence, only 40 percent of respondents to ISACA’s second annual Digital Transformation Barometer express confidence that their organizations can accurately assess the security of systems based on AI and machine learning.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180919005423/en/

ISACA's 2018 Digital Transformation Barometer looks at companies' digital transformation journeys, i ...

ISACA's 2018 Digital Transformation Barometer looks at companies' digital transformation journeys, including the technologies with the biggest impacts and the positive effect of digitally literate leaders. (Graphic: Business Wire)

This becomes especially striking given the potential for serious consequences from maliciously trained AI; survey respondents identify social engineering, manipulated media content and data poisoning as the types of malicious AI attacks that pose the greatest threat within the next five years.

AI/machine learning also continued to rise toward the top of technologies considered to have the highest potential to deliver transformative value to organizations. While placing second in these rankings in the 2017 and 2018 Digital Transformation Barometers, AI/machine learning went from 18 points behind big data in 2017, to just 3 points behind big data in 2018. As the perceived value of AI continues to increase, the proportion of organizations planning to deploy AI continues to increase as well, with a 35 percent increase over 2017.

“Enterprises must make the needed investments in well-trained staffs capable of putting AI safeguards in place,” said Rob Clyde, CISM, ISACA Board Chair and NACD Board Leadership Fellow. “As AI evolves—consider the likely proliferation of self-driving vehicles, or AI systems designed to reduce urban traffic—it will become imperative that enterprises can provide assurance that the AI will not take action that puts people in harm’s way.”

In addition to today’s common uses for AI, such as virtual personal assistants and fraud detection, there are high hopes that AI and machine learning have the potential to cause major breakthroughs across various industries, including helping to accelerate medical research, improving crop yields and assisting law enforcement with cases. These advancements, though, are unfolding so quickly that it often is challenging for organizations to develop the expertise needed to put safeguards in place to account for security vulnerabilities and ethical implications.

While AI/machine learning—along with big data and the public cloud—lead the way in promising transformative value, these technologies also are among the top five facing organizational resistance, with public cloud prompting the highest level of resistance (52 percent).

The 5,847 respondents among ISACA’s global business technology members also identified which emerging technologies appear to be more hype than reality so far. Big data, AI/machine learning and public cloud were the top three technologies that practitioners anticipate will be deployed at their enterprises in the next year, while only 12 percent indicate their organizations will deploy blockchain, and only 6 percent will deploy augmented/virtual reality.

Organizations overwhelmingly pursuing digital transformation

Nine in 10 enterprises (91 percent) are attempting digital transformation as they look to spark innovation and efficiencies, but a majority (64 percent) are encountering challenges in trying to integrate emerging and immature technologies.

However, organizations that embrace emerging technologies have been rewarded. The ISACA data explores the progress organizations have made on this frontier, the extent to which they understand and are adopting transformative technologies, the impact of digital literacy, and the state of this journey through different industries worldwide.

For emerging technologies such as AI, having digitally literate leaders correlates to lower perceived risks, which is key when making the case for deploying technologies.

Last year, ISACA found that just 53 percent of respondents described their leadership as digitally literate. In 2018, that number stayed consistent at 54 percent. The lack of improvement is cause for concern, given the benefits organizations reap when their leaders are digitally literate, including less resistance to deploying emerging technologies.

The global ISACA Digital Transformation Barometer research, conducted in Q1 2018, includes responses from 5,847 ISACA members. Results are at www.isaca.org/digital-transformation-barometer.

About ISACA

Nearing its 50th year, ISACA ® (isaca.org) is a global association helping individuals and enterprises achieve the positive potential of technology. ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations.

www.twitter.com/ISACANews

Contact information

ISACA
Kristen Kessinger, +1.847.660.5512
kkessinger@isaca.org

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha